Selleck Chemicals - Model A2379 -Olaratumab (Anti-PDGFRA / CD140a)

Olaratumab (IMC-3G3; LY3012207) is a fully human IgG1 monoclonal antibody directed against the platelet-derived growth factor receptor alpha (PDGFR alpha) with potential antineoplastic activity. MW: 145.5 kD.